Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting.

Schmidt MM, Wittrup KD.

Mol Cancer Ther. 2009 Oct;8(10):2861-71. doi: 10.1158/1535-7163.MCT-09-0195.

2.

Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.

Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL.

Cancer Res. 1992 Jan 15;52(2):377-84.

3.

Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.

Zahnd C, Kawe M, Stumpp MT, de Pasquale C, Tamaskovic R, Nagy-Davidescu G, Dreier B, Schibli R, Binz HK, Waibel R, Plückthun A.

Cancer Res. 2010 Feb 15;70(4):1595-605. doi: 10.1158/0008-5472.CAN-09-2724. Epub 2010 Feb 2.

4.

Influence of the duration of intravenous drug administration on tumor uptake.

Fouliard S, Chenel M, Marcucci F.

Front Oncol. 2013 Jul 25;3:192. doi: 10.3389/fonc.2013.00192. eCollection 2013.

5.

Practical theoretic guidance for the design of tumor-targeting agents.

Wittrup KD, Thurber GM, Schmidt MM, Rhoden JJ.

Methods Enzymol. 2012;503:255-68. doi: 10.1016/B978-0-12-396962-0.00010-0.

6.

Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization.

Leelawattanachai J, Kwon KW, Michael P, Ting R, Kim JY, Jin MM.

PLoS One. 2015 Apr 22;10(4):e0124440. doi: 10.1371/journal.pone.0124440. eCollection 2015.

7.
8.

CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.

Bao R, Lai CJ, Qu H, Wang D, Yin L, Zifcak B, Atoyan R, Wang J, Samson M, Forrester J, DellaRocca S, Xu GX, Tao X, Zhai HX, Cai X, Qian C.

Clin Cancer Res. 2009 Jun 15;15(12):4046-57. doi: 10.1158/1078-0432.CCR-09-0152. Epub 2009 Jun 9.

9.
10.

Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice.

Vilchis-Juárez A, Ferro-Flores G, Santos-Cuevas C, Morales-Avila E, Ocampo-García B, Díaz-Nieto L, Luna-Gutiérrez M, Jiménez-Mancilla N, Pedraza-López M, Gómez-Oliván L.

J Biomed Nanotechnol. 2014 Mar;10(3):393-404.

PMID:
24730235
11.

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.

Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC.

J Control Release. 2008 Apr 7;127(1):41-9. doi: 10.1016/j.jconrel.2007.12.014. Epub 2007 Dec 26.

PMID:
18234388
12.

Animal modeling of cancer pathology and studying tumor response to therapy.

Langdon SP.

Curr Drug Targets. 2012 Nov;13(12):1535-47. Review.

PMID:
22974396
13.

Cancer-specific ligands identified from screening of peptide-display libraries.

Mori T.

Curr Pharm Des. 2004;10(19):2335-43. Review.

PMID:
15279612
14.

Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.

Mol Pharm. 2009 May-Jun;6(3):905-17. doi: 10.1021/mp800218q.

PMID:
19344115
15.

An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties.

Bae SM, Kim JH, Chung SW, Byun Y, Kim SY, Lee BH, Kim IS, Park RW.

Biomaterials. 2013 Mar;34(8):2077-86. doi: 10.1016/j.biomaterials.2012.11.020. Epub 2012 Dec 11.

PMID:
23245333
16.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Review.

PMID:
25813885
17.

Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.

Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.

Biomaterials. 2012 Dec;33(36):9246-58. doi: 10.1016/j.biomaterials.2012.09.027. Epub 2012 Sep 29.

PMID:
23031530
18.
19.

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, Liu K, Zhang J, Ming P, Huang L, Mei L.

J Biomed Nanotechnol. 2014 Aug;10(8):1509-19.

PMID:
25016651
20.

Supplemental Content

Support Center